Health and Fitness Health and Fitness
Sat, March 10, 2012
Fri, March 9, 2012
Thu, March 8, 2012
Wed, March 7, 2012
Tue, March 6, 2012
[ Tue, Mar 06th 2012 ] - Market Wire
Verotoxin and E. coli 0157
Mon, March 5, 2012
[ Mon, Mar 05th 2012 ] - Market Wire
Sienna Gold Warrants Extended
[ Mon, Mar 05th 2012 ] - Market Wire
30 a.m. ET
Fri, March 2, 2012
Thu, March 1, 2012
Wed, February 29, 2012
Tue, February 28, 2012
[ Tue, Feb 28th 2012 ] - Market Wire
Alere to Acquire eScreen, Inc.
[ Tue, Feb 28th 2012 ] - Market Wire
ICON Acquires PriceSpective
Mon, February 27, 2012

Illumina to Webcast Live Presentations at Upcoming Investment Conferences in March


//health-fitness.news-articles.net/content/2012/ .. at-upcoming-investment-conferences-in-march.html
Published in Health and Fitness on Friday, March 2nd 2012 at 21:40 GMT by Market Wire   Print publication without navigation


SAN DIEGO--([ ])--Illumina, Inc. (NASDAQ: ILMN) today announced that it will webcast the company's presentations at two upcoming investment conferences.

Illumina will webcast its presentation at the Cowen and Company Health Care Conference in Boston, Massachusetts, on March 7, 2012. The live webcast is scheduled to begin at 8:40 a.m. ET and will feature an overview of the company by Jay Flatley, President and Chief Executive Officer.

Illumina will also webcast its presentation at the Barclays Capital Global Healthcare Conference in Miami, Florida, on March 14, 2012. The live webcast is scheduled to begin at 10:45 a.m. ET and will feature an overview of the company by Christian Henry, Senior Vice President and GM, Genomic Solutions, followed by a question and answer session.

These webcasts can be accessed in the Investor Relations section of Illumina's web site under the "Company" tab at [ www.illumina.com ].

About Illumina

Illumina ([ http://www.illumina.com ]) is a leading developer, manufacturer, and marketer of life science tools and integrated systems for the analysis of genetic variation and function. We provide innovative sequencing and array-based solutions for genotyping, copy number variation analysis, methylation studies, gene expression profiling, and low-multiplex analysis of DNA, RNA and protein. We also provide tools and services that are fueling advances in consumer genomics and diagnostics. Our technology and products accelerate genetic analysis research and its application, paving the way for molecular medicine and ultimately transforming healthcare.


Publication Contributing Sources